Should You Invest In Coronado Biosciences Inc(NASDAQ:CNDO), Cellectar Biosciences Inc(NASDAQ:CLRB), and Credit Suisse AM Inc Fund Inc.(NYSEMKT:CIK)?
New York, NY – GDP INSIDER – 11/18/2014.
This article discusses three companies: Coronado Biosciences Inc(NASDAQ:CNDO), Cellectar Biosciences Inc(NASDAQ:CLRB), and Credit Suisse AM Inc Fund Inc.(NYSEMKT:CIK)
Coronado Biosciences Inc(NASDAQ:CNDO)is a Massachusetts-based development stage biopharmaceutical company that develops novel immunotherapy agents. The company has established strategic alliances and commercial agreements with Progenitor Cell Therapy and Freie Universität Berlin. The company, which has a three month average trading volume of 104,469, has a market capitalization of $79.73 million and 44.31 million tradeable shares. Coronado Biosciences has traded within a range of $1.30 to $3.31 over the past 52 weeks.
Cellectar Biosciences Inc(NASDAQ:CLRB)announced a net loss of $0.5 million, or $0.10 per share, for the third quarter on Nov. 11th, 2014. The net loss is $0.8 million less than the figure recorded during third quarter 2013. The stock has traded within a range of $1.76 to $9.20 over the past 52 weeks, yet finished yesterday’s trading at a closing price of $2.84. Despite yesterday’s 4.03% increase in value, Cellectar Biosciences remains just $1.08 above its 52 week low.
Credit Suisse AM Inc Fund Inc.(NYSEMKT:CIK) finished at a closing price of $3.35 yesterday, a figure which is just $0.07 above its 52 week low. On Nov. 7th, Credit Suisse began ex-dividend trading. A cash dividend payment of $0.022 per share will be paid on today.This will be the third quarter in a row Credit Suisse has paid this dividend. The company has a market capitalization of $175.01 million and 52.24 million tradeable shares.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.